With Fermion, start the journey of your innovative API.
01 2Fermion Oy
02 1Alembic Pharmaceuticals Limited
03 3Excella GmbH & Co. KG
04 1Huzhou Zhanwang Pharmaceutical Co. Ltd
05 1Professional Compounding Centers of America dba PCCA
06 1Spectrum Laboratory Products, Inc.
07 1Zhejiang Hisun Pharmaceutical Co., Ltd.
01 1METHOTREXATE
02 1METHOTREXATE SODIUM
03 5Methotrexate
04 1Methotrexate Disodium Salt
05 1methotrexate
06 1methotrexate sodium
01 2China
02 2Finland
03 1India
04 3Luxembourg
05 1U.S.A
06 1United Kingdom
With Fermion, start the journey of your innovative API.
NDC Package Code : 12780-0491
Start Marketing Date : 1981-11-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
With Fermion, start the journey of your innovative API.
NDC Package Code : 12780-6690
Start Marketing Date : 2010-01-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46708-939
Start Marketing Date : 2024-01-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46014-1133
Start Marketing Date : 2017-11-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46014-1023
Start Marketing Date : 2013-05-06
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 46014-1119
Start Marketing Date : 2013-06-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63660-0006
Start Marketing Date : 2017-12-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-1565
Start Marketing Date : 2013-06-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 49452-4601
Start Marketing Date : 2000-12-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 58623-0040
Start Marketing Date : 2012-03-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Methotrexate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Methotrexate, including repackagers and relabelers. The FDA regulates Methotrexate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Methotrexate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Methotrexate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Methotrexate supplier is an individual or a company that provides Methotrexate active pharmaceutical ingredient (API) or Methotrexate finished formulations upon request. The Methotrexate suppliers may include Methotrexate API manufacturers, exporters, distributors and traders.
click here to find a list of Methotrexate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Methotrexate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Methotrexate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Methotrexate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Methotrexate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Methotrexate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Methotrexate suppliers with NDC on PharmaCompass.
We have 7 companies offering Methotrexate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
